Overview
Meckel syndrome (also known as Meckel-Gruber syndrome, MKS, or dysencephalia splanchnocystica) is a severe, lethal autosomal recessive ciliopathy characterized by a classic triad of findings: bilateral renal cystic dysplasia, occipital encephalocele, and postaxial polydactyly. It is one of the most common syndromic forms of neural tube defect. The condition affects multiple organ systems, with the kidneys being the most consistently involved feature (present in nearly 100% of cases). The occipital encephalocele occurs in approximately 60-80% of cases, and polydactyly is seen in about 55-75% of cases. Additional features may include hepatic ductal plate malformation (hepatic fibrosis and bile duct proliferation), pulmonary hypoplasia, cleft lip and palate, cardiac defects, genital anomalies, and central nervous system malformations such as Dandy-Walker malformation and holoprosencephaly. Meckel syndrome is genetically heterogeneous, with pathogenic variants identified in at least 16 genes (including MKS1, TMEM216, TMEM67, CEP290, RPGRIP1L, CC2D2A, NPHP3, TCTN2, B9D1, B9D2, TMEM231, KIF11, TMEM107, NPHP4, CSPP1, and TXNDC15), all of which encode proteins involved in the structure or function of primary cilia or the basal body. This places Meckel syndrome within the broader spectrum of ciliopathies, which includes related but less severe conditions such as Joubert syndrome and Bardet-Biedl syndrome. Diagnosis can often be made prenatally through ultrasound imaging, typically in the second trimester, revealing the characteristic combination of cystic kidneys, encephalocele, and polydactyly. Meckel syndrome is uniformly lethal, with most affected infants being stillborn or dying within hours to days after birth, primarily due to pulmonary hypoplasia and renal failure. There is currently no curative treatment or disease-modifying therapy available. Management is limited to supportive and palliative care. Genetic counseling is essential for affected families, as the recurrence risk is 25% with each pregnancy. Prenatal diagnosis and preimplantation genetic testing are available for families with a known molecular diagnosis.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Meckel syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Meckel syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Meckel syndrome.
Community
No community posts yet. Be the first to share your experience with Meckel syndrome.
Start the conversation →Latest news about Meckel syndrome
No recent news articles for Meckel syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Meckel syndrome
What is Meckel syndrome?
Meckel syndrome (also known as Meckel-Gruber syndrome, MKS, or dysencephalia splanchnocystica) is a severe, lethal autosomal recessive ciliopathy characterized by a classic triad of findings: bilateral renal cystic dysplasia, occipital encephalocele, and postaxial polydactyly. It is one of the most common syndromic forms of neural tube defect. The condition affects multiple organ systems, with the kidneys being the most consistently involved feature (present in nearly 100% of cases). The occipital encephalocele occurs in approximately 60-80% of cases, and polydactyly is seen in about 55-75% of
How is Meckel syndrome inherited?
Meckel syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Meckel syndrome typically begin?
Typical onset of Meckel syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Meckel syndrome?
18 specialists and care centers treating Meckel syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.